SKI Market

Indian Indices

Nifty

25,910.05 -103.40
(-0.40%)

Sensex

84,673.02 -277.93
( -0.33%)

Bank Nifty

58,899.25 -63.45
( -0.11%)

Nifty IT

35,975.20 -400.00
( -1.10%)

Global Indices

Nasdaq

46,604.53 -563.95
(-1.20%)

Dow Jones

6,692.71 -62.40
(-0.92%)

Hang Seng

48,833.62 -1,490.29
(-2.96%)

Nikkei 225

9,519.69 -155.74
(-1.61%)

Forex

USD-INR

88.65 -0.06
(-0.07%)

EUR-INR

103.02 -0.02
(-0.02%)

GBP-INR

116.73 0.00
(0.00%)

JPY-INR

0.57 0.00
(-0.02%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Welcure Drugs & Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524661

INE331C01025

1.0860857

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

2.07

71.68

EPS(TTM)

Face Value()

Div & Yield %

0.28

Particulars(INCOME)	Mar 2025 ( Cr)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)	Mar 2020 ( Cr)
Sales Turnover	24.55	0.00	0.00	0.11	0.13	0.08
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	24.55	0.00	0.00	0.11	0.13	0.08
Other Income	1.91	0.09	0.24	0.00	0.00	0.00
Stock Adjustments	143.52	0.00	0.00	0.00	0.00	0.00
Total Income	169.98	0.09	0.24	0.11	0.13	0.08
EXPENDITURE :
Raw Materials	164.03	0.00	0.00	0.00	0.00	0.00
Power & Fuel Cost	0.00	0.00	0.00	0.00	0.00	0.00
Employee Cost	0.09	0.08	0.03	0.00	0.00	0.00
Other Manufacturing Expenses	0.03	0.00	0.00	0.00	0.00	0.00
Selling & Administrative Expenses	2.78	0.13	0.10	0.08	0.08	0.09
Miscellaneous Expenses	0.17	0.02	0.00	0.00	0.00	0.00
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	167.11	0.23	0.13	0.08	0.08	0.09
Operating Profit	2.88	-0.14	0.10	0.02	0.06	-0.01
Interest	0.09	0.00	0.00	0.00	0.00	0.00
Gross Profit	2.79	-0.14	0.10	0.02	0.06	-0.01
Depreciation	0.01	0.04	0.00	0.00	0.00	0.00
Profit Before Tax	2.78	-0.18	0.10	0.02	0.06	-0.01
Tax	0.61	0.00	0.00	0.00	0.00	0.00
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	0.00	0.00	0.00	0.00	0.00	0.00
Reported Net Profit	2.17	-0.17	0.10	0.02	0.06	-0.01
Extraordinary Items	0.00	0.00	0.02	0.00	0.00	0.00
Adjusted Net Profit	2.17	-0.17	0.08	0.02	0.06	-0.01
Adjustment below Net Profit	0.00	0.00	0.00	0.00	0.00	0.00
P & L Balance brought forward	-12.25	-12.07	-12.18	-12.20	-12.25	-12.25
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
P & L Balance carried down	-10.08	-12.25	-12.07	-12.18	-12.20	-12.25
Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Per Share(Rs)	0.00	0.00	0.00	0.00	0.00	0.00
Earnings Per Share-Unit Curr	0.19	-0.13	0.08	0.02	0.05	-0.01
Earnings Per Share(Adj)-Unit Curr	0.02	-0.01	0.01	0.00	0.00	0.00
Book Value-Unit Curr	9.12	1.00	1.13	0.08	0.06	0.01
Book Value(Adj)-Unit Curr	0.83	0.09	0.10	0.01	0.01	0.00

25,910.05 -103.40 (-0.40%)

84,673.02 -277.93 ( -0.33%)

58,899.25 -63.45 ( -0.11%)

35,975.20 -400.00 ( -1.10%)

46,604.53 -563.95 (-1.20%)

6,692.71 -62.40 (-0.92%)

48,833.62 -1,490.29 (-2.96%)

9,519.69 -155.74 (-1.61%)

88.65 -0.06 (-0.07%)

103.02 -0.02 (-0.02%)

116.73 0.00 (0.00%)

0.57 0.00 (-0.02%)